GlassScriptPhysician profile
Nathalia Idelevitch
NPI 1447440029
$5,329.21
in general payments reported to CMS, 2019-2025
35 companies · $606 in 2025
The $606 reported for 2025 was more than what 84% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,707 · 2020: $579 · 2021: $584 · 2022: $683 · 2023: $491 · 2024: $680 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $997.67 | 2019-2022 | |
| Amgen INC. | $805.66 | 2019-2025 | Otezla, Repatha, Otezla |
| Abbvie INC. | $584.08 | 2019-2025 | |
| Lilly USA, LLC | $528.51 | 2019-2023 | Mounjaro |
| Aimmune Therapeutics, INC. | $410.54 | 2025 | Zenpep |
| Novartis Pharmaceuticals Corporation | $283.32 | 2021-2023 | |
| Corcept Therapeutics | $181.29 | 2024 | Korlym |
| Amarin Pharma, INC. | $177.08 | 2019-2022 | |
| Emd Serono, INC. | $125.00 | 2023 | Bavencio |
| Dexcom, INC. | $125.00 | 2021 | |
| Vivus LLC | $89.53 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $86.12 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.22 | 2019 | |
| Astellas Pharma US INC | $69.79 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $66.18 | 2019 | |
| Pfizer INC. | $63.21 | 2019-2020 | |
| Medtronic, INC. | $55.47 | 2025 | Minimed 780g |
| Horizon Therapeutics Plc | $48.79 | 2020-2022 | |
| Shield Therapeutics INC | $48.71 | 2023-2024 | Accrufer |
| Regeneron Healthcare Solutions, INC. | $45.62 | 2019-2022 | |
| Abbott Laboratories | $44.98 | 2022-2023 | Freestyle Libre 3 |
| Endo Pharmaceuticals INC. | $42.52 | 2019-2020 | |
| Intra-Sana Laboratories | $42.36 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Astrazeneca Pharmaceuticals LP | $39.86 | 2021-2022 | |
| Novo Nordisk INC | $39.47 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $28.29 | 2019 | |
| Ironwood Pharmaceuticals, INC | $24.80 | 2021 | |
| Gilead Sciences, INC. | $22.85 | 2019 | |
| Radius Health, INC. | $22.40 | 2019 | |
| Genentech USA, INC. | $18.75 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.48 | 2019 | |
| Hologic Sales and Service, LLC | $16.10 | 2024 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $16.00 | 2024 | |
| Seqirus USA INC | $14.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathalia Idelevitch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.